A narrative review of the clinical development of CDK4/6 inhibitor abemaciclib in breast cancer
Translational Breast Cancer ResearchPeer ReviewedYang Liu +32022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support